2m 2m 2m 2m 2m 2m 2m
- $38.2MMarket Cap
- -32.50%1-Year Change
- N/AIndustry
NEPHROS (NEPH)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 25
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Nephros, Inc. (Nasdaq: NEPH), a water technology and filtration solutions company, announced that its President and CEO Robert Banks will present at Maxim Group LLC's virtual 'Health, Wellness & Longevity' conference on July 22, 2026, at 10:00 a.m. ET. The conference brings together leaders from companies innovating in beverages, food, supplements, and longevity sectors to discuss consumer preferences and emerging trends.
07/20/2026, 7:00 AM • GlobeNewswire
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”
Nephros, Inc. announced a virtual investor event scheduled for July 16, 2026, titled 'Beyond Filtration: The Nephros Model in Action.' The event will showcase the company's differentiated approach to water safety beyond filtration products, featuring insights from field leaders, the Nephros Water Institute, and company leadership. The program will discuss growth opportunities, strategic priorities, and include a Q&A session.
06/18/2026, 7:00 AM • GlobeNewswire
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
Nephros, Inc. announced that its ultrafiltration technology can effectively capture microplastics and nanoplastics from drinking water, positioning the company to address emerging water quality concerns. The announcement follows the U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List (CCL 6). Nephros' filters feature pore sizes as small as 5 nanometers, enabling removal of particles smaller than conventional filtration technologies can address.
06/16/2026, 7:00 AM • GlobeNewswire
Nephros, Inc. announced an expansion of its water safety support capabilities following Director of Business Development Brianne McGuire's ASSE 12080 Legionella Water Safety and Management Specialist Certification. The company now offers Water Management Program (WMP) development services to healthcare facilities and complex buildings, creating a new revenue stream through chargeable consulting services while strengthening its value proposition in waterborne pathogen risk reduction.
04/01/2026, 9:00 AM • GlobeNewswire
Nephros Launches the Nephros Water Institute to Lead National Water Safety Education
Nephros Inc. launched the Nephros Water Institute to provide educational resources on water safety, targeting professionals across healthcare and related sectors through webinars, speaking engagements, and tailored training programs.
12/11/2025, 9:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 10/23/2026
Company Profile
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Key Executives
- Robert Banks
- Judy F. Krandel
- Greg Lucas
- Michael Milman
- Vashone R. Thomas
Current Ownership Distribution
- Institutions87.3M (79.23%)
- Insiders19.4M (17.62%)
- Mutual Funds3.5M (3.14%)
- Other0 (0.00%)